MICHELE SWAN: Open Payments
NPI 1558609883 · STEUBENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,874 in 153 payments from 18 companies in 2025. Trend: 2023 $2,195 · 2024 $3,001 · 2025 $2,874
Food & beverage: $2,874
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 41 | $774 |
| ABBVIE INC. | 36 | $705 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $274 |
| Phathom Pharmaceuticals, Inc. | 7 | $166 |
| Novo Nordisk Inc | 5 | $97 |
| Ardelyx, Inc. | 5 | $88 |
| Janssen Biotech, Inc. | 3 | $64 |
| Gilead Sciences, Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $56 |
Products named: REZDIFFRA, XIFAXAN, ENTYVIO, LINZESS, RINVOQ, VOQUEZNA, CREON, MAVYRET.
Industry payments across OH — which companies pay providers there.
